Calcitonin gene-related peptide improves skin flap survival and tissue inflammation

G. Gherardini, A. Gürlek, S. M. Milner, A. Matarasso, G. R D Evans, J. Jernbeck, T. Lundeberg

Research output: Contribution to journalArticle

Abstract

The effects of systemic administration of calcitonin gene-related peptide (CGRP) on survival and inflammation of experimental skin flaps subjected to prolonged arterial ischemia were studied. An island groin flap was elevated in the rat. The femoral artery was occluded for 8,10,12 or 14 h in four groups of 10 rats. In a group of 10 sham-operated control animals, the femoral artery was not occluded. After ischemia, blood flow was restored and flap survival evaluated at day 7. Following 12 h of ischemia, three flaps (30%) survived, compared with 100% survival of the control group. In the second part of the study the effects of CGRP on flap survival were assessed. Eighty flaps were rendered ischemic for 12 h, and received systemic CGRP (10-7, 10-8, 10-9,10-10 M) or saline (control) at the end of the ischemia period. Administration of CGRP (10-7 M) significantly increased the number of flaps surviving compared with the control. The effect of systemic pretreatment of the animals with the CGRP receptor antagonist CGRP8-37, followed by CGRP (10-7 M) treatment was also evaluated in 10 flaps. Flap survival in this group was 10%. In the third part of the study the anti-inflammatory effects of CGRP were evaluated. Forty rats were subjected to arterial ischemia for 12 h, and received systemic CGRP (10-7 M), or saline at the end of the period of ischemia. The animals were sacrificed at 24 h and flap tissue samples were obtained. Myeloperoxidase (MPO) analysis was used as marker of neutrophil accumulation. CGRP (10-7 M) significantly reduced the 24 h MPO accumulation in the flap, compared with saline treatment. A group of animals was pretreated with CGRP8-37, followed by CGRP (10-7 M), and a significant increase of MPO accumulation was seen, compared with the group treated only with CGRP. This study suggests that CGRP has a beneficial effect on survival of the rat ischemic groin flap, and diminishes the inflammatory response to the ischemic insult.

Original languageEnglish (US)
Pages (from-to)269-273
Number of pages5
JournalNeuropeptides
Volume32
Issue number3
DOIs
StatePublished - 1998
Externally publishedYes

Fingerprint

Tissue Survival
Calcitonin Gene-Related Peptide
Skin
Tissue
Inflammation
Flaps
Ischemia
Rats
Animals
Peroxidase
Jetties
Groin
Femoral Artery
Calcitonin Gene-Related Peptide Receptors
Surgical Flaps
Neutrophils
Blood
Anti-Inflammatory Agents

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Neurology
  • Endocrinology, Diabetes and Metabolism
  • Cellular and Molecular Neuroscience
  • Neuroscience(all)
  • Biochemistry

Cite this

Gherardini, G., Gürlek, A., Milner, S. M., Matarasso, A., Evans, G. R. D., Jernbeck, J., & Lundeberg, T. (1998). Calcitonin gene-related peptide improves skin flap survival and tissue inflammation. Neuropeptides, 32(3), 269-273. https://doi.org/10.1016/S0143-4179(98)90047-6

Calcitonin gene-related peptide improves skin flap survival and tissue inflammation. / Gherardini, G.; Gürlek, A.; Milner, S. M.; Matarasso, A.; Evans, G. R D; Jernbeck, J.; Lundeberg, T.

In: Neuropeptides, Vol. 32, No. 3, 1998, p. 269-273.

Research output: Contribution to journalArticle

Gherardini, G, Gürlek, A, Milner, SM, Matarasso, A, Evans, GRD, Jernbeck, J & Lundeberg, T 1998, 'Calcitonin gene-related peptide improves skin flap survival and tissue inflammation', Neuropeptides, vol. 32, no. 3, pp. 269-273. https://doi.org/10.1016/S0143-4179(98)90047-6
Gherardini G, Gürlek A, Milner SM, Matarasso A, Evans GRD, Jernbeck J et al. Calcitonin gene-related peptide improves skin flap survival and tissue inflammation. Neuropeptides. 1998;32(3):269-273. https://doi.org/10.1016/S0143-4179(98)90047-6
Gherardini, G. ; Gürlek, A. ; Milner, S. M. ; Matarasso, A. ; Evans, G. R D ; Jernbeck, J. ; Lundeberg, T. / Calcitonin gene-related peptide improves skin flap survival and tissue inflammation. In: Neuropeptides. 1998 ; Vol. 32, No. 3. pp. 269-273.
@article{a2047009caaa405cba68616ed32cc8ed,
title = "Calcitonin gene-related peptide improves skin flap survival and tissue inflammation",
abstract = "The effects of systemic administration of calcitonin gene-related peptide (CGRP) on survival and inflammation of experimental skin flaps subjected to prolonged arterial ischemia were studied. An island groin flap was elevated in the rat. The femoral artery was occluded for 8,10,12 or 14 h in four groups of 10 rats. In a group of 10 sham-operated control animals, the femoral artery was not occluded. After ischemia, blood flow was restored and flap survival evaluated at day 7. Following 12 h of ischemia, three flaps (30{\%}) survived, compared with 100{\%} survival of the control group. In the second part of the study the effects of CGRP on flap survival were assessed. Eighty flaps were rendered ischemic for 12 h, and received systemic CGRP (10-7, 10-8, 10-9,10-10 M) or saline (control) at the end of the ischemia period. Administration of CGRP (10-7 M) significantly increased the number of flaps surviving compared with the control. The effect of systemic pretreatment of the animals with the CGRP receptor antagonist CGRP8-37, followed by CGRP (10-7 M) treatment was also evaluated in 10 flaps. Flap survival in this group was 10{\%}. In the third part of the study the anti-inflammatory effects of CGRP were evaluated. Forty rats were subjected to arterial ischemia for 12 h, and received systemic CGRP (10-7 M), or saline at the end of the period of ischemia. The animals were sacrificed at 24 h and flap tissue samples were obtained. Myeloperoxidase (MPO) analysis was used as marker of neutrophil accumulation. CGRP (10-7 M) significantly reduced the 24 h MPO accumulation in the flap, compared with saline treatment. A group of animals was pretreated with CGRP8-37, followed by CGRP (10-7 M), and a significant increase of MPO accumulation was seen, compared with the group treated only with CGRP. This study suggests that CGRP has a beneficial effect on survival of the rat ischemic groin flap, and diminishes the inflammatory response to the ischemic insult.",
author = "G. Gherardini and A. G{\"u}rlek and Milner, {S. M.} and A. Matarasso and Evans, {G. R D} and J. Jernbeck and T. Lundeberg",
year = "1998",
doi = "10.1016/S0143-4179(98)90047-6",
language = "English (US)",
volume = "32",
pages = "269--273",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "3",

}

TY - JOUR

T1 - Calcitonin gene-related peptide improves skin flap survival and tissue inflammation

AU - Gherardini, G.

AU - Gürlek, A.

AU - Milner, S. M.

AU - Matarasso, A.

AU - Evans, G. R D

AU - Jernbeck, J.

AU - Lundeberg, T.

PY - 1998

Y1 - 1998

N2 - The effects of systemic administration of calcitonin gene-related peptide (CGRP) on survival and inflammation of experimental skin flaps subjected to prolonged arterial ischemia were studied. An island groin flap was elevated in the rat. The femoral artery was occluded for 8,10,12 or 14 h in four groups of 10 rats. In a group of 10 sham-operated control animals, the femoral artery was not occluded. After ischemia, blood flow was restored and flap survival evaluated at day 7. Following 12 h of ischemia, three flaps (30%) survived, compared with 100% survival of the control group. In the second part of the study the effects of CGRP on flap survival were assessed. Eighty flaps were rendered ischemic for 12 h, and received systemic CGRP (10-7, 10-8, 10-9,10-10 M) or saline (control) at the end of the ischemia period. Administration of CGRP (10-7 M) significantly increased the number of flaps surviving compared with the control. The effect of systemic pretreatment of the animals with the CGRP receptor antagonist CGRP8-37, followed by CGRP (10-7 M) treatment was also evaluated in 10 flaps. Flap survival in this group was 10%. In the third part of the study the anti-inflammatory effects of CGRP were evaluated. Forty rats were subjected to arterial ischemia for 12 h, and received systemic CGRP (10-7 M), or saline at the end of the period of ischemia. The animals were sacrificed at 24 h and flap tissue samples were obtained. Myeloperoxidase (MPO) analysis was used as marker of neutrophil accumulation. CGRP (10-7 M) significantly reduced the 24 h MPO accumulation in the flap, compared with saline treatment. A group of animals was pretreated with CGRP8-37, followed by CGRP (10-7 M), and a significant increase of MPO accumulation was seen, compared with the group treated only with CGRP. This study suggests that CGRP has a beneficial effect on survival of the rat ischemic groin flap, and diminishes the inflammatory response to the ischemic insult.

AB - The effects of systemic administration of calcitonin gene-related peptide (CGRP) on survival and inflammation of experimental skin flaps subjected to prolonged arterial ischemia were studied. An island groin flap was elevated in the rat. The femoral artery was occluded for 8,10,12 or 14 h in four groups of 10 rats. In a group of 10 sham-operated control animals, the femoral artery was not occluded. After ischemia, blood flow was restored and flap survival evaluated at day 7. Following 12 h of ischemia, three flaps (30%) survived, compared with 100% survival of the control group. In the second part of the study the effects of CGRP on flap survival were assessed. Eighty flaps were rendered ischemic for 12 h, and received systemic CGRP (10-7, 10-8, 10-9,10-10 M) or saline (control) at the end of the ischemia period. Administration of CGRP (10-7 M) significantly increased the number of flaps surviving compared with the control. The effect of systemic pretreatment of the animals with the CGRP receptor antagonist CGRP8-37, followed by CGRP (10-7 M) treatment was also evaluated in 10 flaps. Flap survival in this group was 10%. In the third part of the study the anti-inflammatory effects of CGRP were evaluated. Forty rats were subjected to arterial ischemia for 12 h, and received systemic CGRP (10-7 M), or saline at the end of the period of ischemia. The animals were sacrificed at 24 h and flap tissue samples were obtained. Myeloperoxidase (MPO) analysis was used as marker of neutrophil accumulation. CGRP (10-7 M) significantly reduced the 24 h MPO accumulation in the flap, compared with saline treatment. A group of animals was pretreated with CGRP8-37, followed by CGRP (10-7 M), and a significant increase of MPO accumulation was seen, compared with the group treated only with CGRP. This study suggests that CGRP has a beneficial effect on survival of the rat ischemic groin flap, and diminishes the inflammatory response to the ischemic insult.

UR - http://www.scopus.com/inward/record.url?scp=0031859986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031859986&partnerID=8YFLogxK

U2 - 10.1016/S0143-4179(98)90047-6

DO - 10.1016/S0143-4179(98)90047-6

M3 - Article

C2 - 10189062

AN - SCOPUS:0031859986

VL - 32

SP - 269

EP - 273

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 3

ER -